[Skip to Navigation]
Sign In
July 2, 2020

Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes

Author Affiliations
  • 1Intermountain Medical Center Heart Institute, Salt Lake City, Utah
  • 2Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California
  • 3Division of Endocrinology, Albert Einstein College of Medicine, Bronx, New York
  • 4Cardiology Division, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
JAMA. 2020;324(4):341-342. doi:10.1001/jama.2020.3908

Caloric restriction and weight loss beneficially influence the development and progression of type 2 diabetes. Weight loss in patients with type 2 diabetes, whether through surgical or dietary interventions, leads to improvement in glycemic control, hypertension, abnormal lipid levels, and nonalcoholic fatty liver disease.1 Caloric restriction is an effective method for weight loss when followed consistently over time. Research suggests that intermittent fasting may also influence type 2 diabetes.

Add or change institution